Abstract
Novel activities of bafilomycin A1, a macrolide antibiotic known as an inhibitor of V-ATPases, were discovered. Bafilomycin A1 induced uptake of potassium ions by energized mitochondria and caused mitochondrial swelling, loss of membrane potential, uncoupling of oxidative phosphorylation, inhibition of the maximal respiration rates, and induced pyridine nucleotide oxidation. The mitochondrial effects provoked by nanomolar concentrations of bafilomycin A1 were connected to its activity as a potent, K+-specific ionophore. The K+ ionophoric activity of bafilomycin A1 was observed also in black lipid membranes, indicating that it was an inherent property of the bafilomycin A1 molecule. It was found that bafilomycin A1 is a K+ carrier but not a channel former. Bafilomycin A1 is the first and currently unique macrolide antibiotic with K+ ionophoric properties. The novel properties of bafilomycin A1 may explain some of the biological effects of this plecomacrolide antibiotic, independent of V-ATPase inhibition.
Similar content being viewed by others
References
Abdalah R, Wei L, Francis K, Yu SP (2006) Neurosci Lett 405:68–73
Bowman B, Bowman E (2002) J Biol Chem 277:3965–3972
Bowman EJ, Siebers A, Altendorf K (1988) Proc Natl Acad Sci U S A 85:7972–7976
Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Metivier D, Meley D, Souquere S, Yoshimori T, Pierron G, Codogno P, Kroemer G (2005) Mol Cell Biol 25:1025–1040
Broekemeyer KM, Dempsey ME, Pfeiffer DR (1989) J Biol Chem 264:7826–7830
Clarke’s Analysis of drugs and poisons (2006) London, Pharmaceutical, Electronic version. http://www.medicinescomplete.com/mc/clarke/current/CLK1480.htm (Accessed June 29, 2007)
Crompton M, Ellinger H, Costi A (1988) Biochem J 255:357–360
Dröse S, Altendorf K (1997) J Exp Biol 200:1–8
Dröse S, Boddien K, Gassel M, Ingenhorst G, Zeeck A, Altendorf K (2001) Biochemistry 40:2816–2825
Emaus RK, Grunwald R, Lemasters J (1986) Biochim Biophys Acta 850:436–448
Gagliardi S, Rees M, Farina C (1999) Curr Med Chem 6(12):1197–1212
Garlid KD, Paucek P (2003) Biochim Biophys Acta 1606:23–41
Hishita T, Tada-Oikawa S, Tohyama K, Muira Y, Nishihara T, Tohyama Y, Yoshida Y, Uchiyma T, Kawanishi S (2001) Cancer Res 61(7):2878–2884
Hong J, Nakano Y, Yokomakura A, Ishihara K, Kim S, Kang YS, Ohuchi K (2006) J Pharmacol Exp Ther 319(2):672–681
Hoornstra D, Andersson MA, Mikkola R, Salkinoja-Salonen MS (2003) Toxicol In Vitro 17:745–751
Hoornstra D, Andersson M, Johansson T, Pirhonen T, Hatakka M, Salkinoja-Salonen MS (2004) Altern Lab Anim 32(4):407–416
Inai Y, Yabuki M, Kanno T, Akiyama J, Yasuda T, Utsumi K (1997) Cell Struct Funct 22:555–563
Kinoshita K, Hidaka H, Ohkuma S (1994) FEBS Lett 337:221–225
Kinoshita K, Waritani T, Noto M, Takizawa K, Minemoto Y, Nishikawa Y, Ohkuma S (1996) FEBS Lett 398:61–66
Lin HI, Lee YJ, Chen BF, Tsai MC, Lu JL, Chou CJ, Jow GM (2005) Cancer Lett 230:248–259
Mikkola R, Saris N-EL, Grigoriev PA, Andersson MA, Salkinoja-Salonen MS (1999) Eur J Biochem 263:112–117
Moriyama Y, Futai M (1990) J Biol Chem 265:9165–9169
Moriyama Y, Nelson N (1989) J Biol Chem 264:18445–18450
Mueller P, Rudin DO, Tien HT, Wescott WC (1963) J Phys Chem 67:534–535
Nakashima S, Hiraku Y, Tada-Oikawa S, Hishita T, Gabbazza EC, Tamaki S, Imoto I, Adachi Y, Kawanishi S (2003) J Biochem (Tokyo) 134:359–364
Nishihara T, Akifusa S, Koseki T, Kato S, Muro M, Hanada N (1995) Biochim Biophys Res Comm 212:255–262
Ohkuma S, Shimizu S, Noto M, Sai Y, Kinoshita K, Tamura HO (1993) In Vitro Cell Dev Biol Anim 29:862–866
Ohta T, Arakawa H, Futagami F, Fushida S, Kitagawa H, Kayahara M, Nakagawa T, Miwa K, Kurashima K, Numata M, Kitamura Y, Terada T, Ohkuma S (1998) J Pathol 85:324–330
Okahashi N, Nakamura I, Jimi E, Koide M, Suda T, Nishihara T (1997) J Bone Miner Res 12:1116–1123
Paananen A, Mikkola R, Sareneva T, Matikainen S, Hess M, Andersson M, Julkunen I, Salkinoja-Salonen MS, Timonen T (2002) Clin Exp Immunol 129:420–428
Scifinder, Version (2006) Chemical Abstracts Service, Columbus Ohio. LogP values for CAS numbers 114-07-8, 80214-83-1, 81103-11-9, 83905-01-5, 88899-55-2; calculated using ACD/Labs software version 8.14; ACD/Labs 1994–2007
Shacka JJ, Klocke BJ, Roth KA (2006a) Autophagy 2:228–230
Shacka JJ, Klocke BJ, Shibata M, Uchiyama Y, Datta G, Schmidt RE, Roth KA (2006b) Mol Pharmacol 69:1125–1136
Shomi K, Omura S (2002) Discovery of new macrolides. In: Omura S (ed) Macrolide antibiotics, Chemistry, Biology and Practice, 2nd edn. Academic Press, Amsterdam London New York, pp 2–56
Sunazuka T, Omura S, Iwasaki S, Omura S (2002) Chemical modification of macrolides. In: Omura S (ed) Macrolide antibiotics, Chemistry, Biology and Practice, 2nd edn. Academic Press, Amsterdam London New York, pp 99–180
Takahashi N (2002) Mode of action of FK506 and rapamycin. In: Omura S (ed) Macrolide antibiotics, Chemistry, Biology and Practice, 2nd edn. Academic Press, Amsterdam London New York, pp 577–621
Tanigaki K, Sasaki S, Ohkuma S (2003) FEBS Lett 537:79–84
Teplova V, Mikkola R, Tonshin AA, Saris N-EL, Salkinoja-Salonen MS (2006) Toxicol Appl Pharmacol 210:39–46
Umata T, Moriyama Y, Futai M, Mekada E (1990) J Biol Chem 265:21940–21945
Xu J, Feng HT, Wang C, Yip KH, Pavlos N, Papadimitriou JM, Wood D, Zheng MH (2003) J Cell Biochem 88:1256–1264
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Teplova, V.V., Tonshin, A.A., Grigoriev, P.A. et al. Bafilomycin A1 is a potassium ionophore that impairs mitochondrial functions. J Bioenerg Biomembr 39, 321–329 (2007). https://doi.org/10.1007/s10863-007-9095-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-007-9095-9